The Cancer Moonshot’s Blue Ribbon Panel Report summarized ten scientific priorities to accelerate cancer research, including Recommendation F to minimize the debilitating side effects from cancer treatment through development of guidelines for routine monitoring and management of patient-reported symptoms. In response to this recommendation, the IMPACT consortium was established to integrate evidence-based symptom management into clinical care throughout the cancer trajectory and to study the implementation and barriers to adoption of this care practice.